CAS 141790-23-0|Fozivudine tidoxil

Introduction：Basic information about CAS 141790-23-0|Fozivudine tidoxil, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.

Table of Contents

1. Names
2. Fozivudine tidoxil BiologicalActivity
3. Chemical & Physical Properties
4. Synonyms

Common Name	Fozivudine tidoxil
CAS Number	141790-23-0	Molecular Weight	745.95000
Density	/	Boiling Point	/
Molecular Formula	C₃₅H₆₄N₅O₈PS	Melting Point	/
MSDS	/	Flash Point	/

Names

Name	[(2S,3S,5R)-3-azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl (2-decoxy-3-dodecylsulfanylpropyl) hydrogen phosphate
Synonym	More Synonyms

Fozivudine tidoxil BiologicalActivity

Description	Fozivudine tidoxil (BM-211290) is an orally active thioether lipid-zidovudine (ZDV) conjugate with anti-HIV activity. Fozivudine tidoxil, a member of the NRTI family of drug, is incorporated into the newly synthesized strand of DNA during intracellular viral replication and irreversibly binds viral RT which disrupts viral reverse-transcription[1][2].
Related Catalog	Signaling Pathways >>Anti-infection >>HIVResearch Areas >>InfectionSignaling Pathways >>Cell Cycle/DNA Damage >>DNA/RNA Synthesis
Target	HIV
In Vitro	Fozivudine tidoxil (BM-211290) is a member of the nucleoside analogue reverse transcriptase inhibitor (NRTI) family[1].
In Vivo	Fozivudine tidoxil (BM-211290; 45 mg/kg; PO; twice daily; one day before FIV challenge for a total of six weeks) is effective at lowering plasma- and cell-associated viremia at two weeks post-FIV infection[1]. Animal Model: Specific pathogen-free cats at 6 months of age[1] Dosage: 45 mg/kg Administration: PO; twice daily; one day before FIV challenge for a total of six weeks Result: Effective at lowering plasma- and cell-associated viremia at two weeks post-feline immunodeficiency virus (FIV) infection with a trend toward lower plasma- and cell- associated viremia at four and six weeks post-infection (PI).
References	[1]. Michelle M Miller, et al. Administration of Fozivudine Tidoxil as a Single-Agent Therapeutic During Acute Feline Immunodeficiency Virus Infection Does Not Alter Chronic Infection. Viruses. 2012 Jun;4(6):954-62. [2]. P M Girard, et al. Phase II Placebo-Controlled Trial of Fozivudine Tidoxil for HIV Infection: Pharmacokinetics, Tolerability, and Efficacy. J Acquir Immune Defic Syndr. 2000 Mar 1;23(3):227-35.

Chemical & Physical Properties

Molecular Formula	C₃₅H₆₄N₅O₈PS
Molecular Weight	745.95000
Exact Mass	745.42100
PSA	214.20000
LogP	8.99006
InChIKey	IBHARWXWOCPXCR-WELGVCPWSA-N
SMILES	CCCCCCCCCCCCSCC(COP(=O)(O)OCC1OC(n2cc(C)c(=O)[nH]c2=O)CC1N=[N+]=[N-])OCCCCCCCCCC

Synonyms

fozivudine tidoxil

fosphenyloin

Fosfenitoina

Fosphenytoinum

3-Phosphoryloxymethyl-diphenylhydantoin

HMPDP

Fosphenytoine

oxcarbamazepine

Prodilantin

Fosphenytoin

3-phosphoryloxymethyl-5,5-diphenylhydantoin

Recommended......